For decades, researchers have inserted different types of human cells into nonhuman animals at various stages of development to advance our understanding of human biological processes and identify new investigational therapies. When these studies involve the transfer of human stem cells (or their direct derivatives),
a variety of moral questions are raised, and stem cell-based chimeric research has been surrounded by cross-disciplinary debate about whether such scientific work should take place and how best to respond to the ethical and policy issues it raises. This webinar will provide an overview of the debate and regulatory issues in chimeric research and discuss one or two illustrative case studies that identify challenges for IRB, IACUC, and ESCRO professionals. Discussion will focus on ways to improve oversight, and speakers will address questions from participants. Time will also be devoted to answering attendee questions.